“A Sensitive Bioanalytical Method Development and Validation of Cabozantinib in Human Plasma by LC-ESI-MS MS”. 2018. Brazilian Journal of Pharmaceutical Sciences 54 (2): e17163. https://doi.org/10.1590/s2175-97902018000217163.